STOCK TITAN

[SCHEDULE 13G/A] MASIMO CORP Amended Passive Investment Disclosure

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Analyzing...





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) Aggregate amount beneficially owned is comprised of (a) 5,000 shares of the Issuer's common stock held in the name of the Reporting Person, (b) 1,273,691 shares of the Issuer's common stock held in two trusts for which the Reporting Person is the sole trustee, (c) 1,077,021 shares of the Issuer's common stock held by a limited liability company that is owned by three trusts for which the Reporting Person is not the trustee, (d) 38,735 shares of the Issuer's common stock held by the Reporting Person's spouse, (e) 368,252 shares of the Issuer's common stock subject to the Exercised Options (as defined in Footnote (1) to Item 4(a) below) that are subject to a dispute between the Issuer and the Reporting Person as described in Footnote (1) to Item 4(a) below, (f) 2,700,000 shares of the Issuer's common stock that are subject to the RSU Award (as defined in Footnote (2) to Item 4(a) below) that is subject to a dispute between the Issuer and the Reporting Person as further described in Footnote (2) to Item 4(a) below, (g) 158,450 shares of the Issuer's common stock subject to the Accelerated Options (as defined in Footnote (3) to Item 4(a) below) that are subject to a dispute between the Issuer and the Reporting Person as described in Footnote (3) to Item 4(a) below, (h) 198,225 shares of the Issuer's common stock subject to the PSUs (as defined in Footnote (4) to Item 4(a) below) that are subject to a dispute between the Issuer and the Reporting Person as described in Footnote (4) to Item 4(a) below, and (i) 85,255 shares of the Issuer's common stock subject to the Vested Options (as defined in Footnote (5) to Item 4 (a) below) that are subject to a dispute between the Issuer and the Reporting Person as described in Footnote (5) to Item 4(a) below. (2) Percent of class was calculated based on: (a) 53,713,949 shares of the Issuer's common stock outstanding as of September 27, 2025 (as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 27, 2025 filed with the Securities and Exchange Commission on November 4, 2025), (b) 368,252 shares of the Issuer's common stock issuable upon exercise of the Exercised Options that have not yet been issued by the Issuer to the Reporting Person, (c) 2,700,000 shares of the Issuer's common stock issuable underlying the RSU Award that have not yet been issued by the Issuer to the Reporting Person, (d) 158,450 shares of the Issuer's common stock issuable upon exercise of the Accelerated Options that should have been deemed vested in full on October 24, 2024, (e) 198,225 shares of the Issuer's common stock subject to the PSUs that should have been accelerated and issued by the Issuer to the Reporting Person on October 24, 2024, and (f) 85,255 shares of the Issuer's common stock subject to the Vested Options.


SCHEDULE 13G



Joe Kiani
Signature:/s/ Joe Kiani
Name/Title:Individual
Date:02/13/2026
Exhibit Information

N/A

Masimo Corp

NASDAQ:MASI

MASI Rankings

MASI Latest News

MASI Latest SEC Filings

MASI Stock Data

6.99B
20.05M
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
IRVINE